a positive trendp = 0.29
concluded that in patients presenting with STEMI, there was a positive trend towards further reduction of MACE (0.0% vs. 5.4%, p = 0.29) and a significantly less late lumen loss (− 0.09 ± 0.09 vs. 0.10 ± 0.19, p < 0.05) at 6 months in the DEB treatment group than in the DES treatment group [ 15 ].